| Type |
Details |
Score |
| Allele |
| Name: |
transgene insertion 402, Marta I Gallego |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
hepatocyte growth factor; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
hepatocyte growth factor; endonuclease-mediated mutation 3, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
hepatocyte growth factor; endonuclease-mediated mutation 4, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Inserted expressed sequence, Null/knockout |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gallego MI |
| Year: |
2003 |
| Journal: |
Oncogene |
| Title: |
Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways. |
| Volume: |
22 |
| Issue: |
52 |
| Pages: |
8498-508 |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| Protein Coding Gene |
| Type: |
protein_coding_gene |
| Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
| Allele |
| Name: |
hepatocyte growth factor; targeted mutation 1.1, Thomas B Friedman |
| Allele Type: |
Targeted |
| Attribute String: |
Not Specified |
|
•
•
•
•
•
|
| Allele |
| Name: |
hepatocyte growth factor; targeted mutation 1, Thomas B Friedman |
| Allele Type: |
Targeted |
| Attribute String: |
Not Specified |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lindner G |
| Year: |
2000 |
| Journal: |
FASEB J |
| Title: |
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. |
| Volume: |
14 |
| Issue: |
2 |
| Pages: |
319-32 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Hgf)1Paus/? |
| Background: |
Not Specified |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Wap-Hgf)402Mig/? |
| Background: |
FVB/N-Tg(Wap-Hgf)402Mig |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Wap-Hgf)402Mig/? |
| Background: |
involves: FVB/N |
| Zygosity: |
ot |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Hgf/Hgf |
| Background: |
B6.Cg-Hgf/Tbf |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| DO Term |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Hgf/Hgf |
| Background: |
B6.Cg-Hgf/Tbf |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Attar MA |
| Year: |
2012 |
| Journal: |
Exp Cell Res |
| Title: |
CNK3 and IPCEF1 produce a single protein that is required for HGF dependent Arf6 activation and migration. |
| Volume: |
318 |
| Issue: |
3 |
| Pages: |
228-37 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang X |
| Year: |
2003 |
| Journal: |
Am J Physiol Renal Physiol |
| Title: |
Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. |
| Volume: |
284 |
| Issue: |
6 |
| Pages: |
F1216-25 |
|
•
•
•
•
•
|
| Allele |
| Name: |
hepatocyte growth factor; targeted mutation 1, Naomi Kitamura |
| Allele Type: |
Targeted |
| Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
| Allele |
| Name: |
hepatocyte growth factor; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Hgf/Hgf |
| Background: |
involves: 129S4/SvJae * C57BL/6 |
| Zygosity: |
hm |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Herter S |
| Year: |
2005 |
| Journal: |
Biochem J |
| Title: |
Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. |
| Volume: |
390 |
| Issue: |
Pt 1 |
| Pages: |
125-36 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ganesan R |
| Year: |
2011 |
| Journal: |
Mol Cancer Res |
| Title: |
Proteolytic activation of pro-macrophage-stimulating protein by hepsin. |
| Volume: |
9 |
| Issue: |
9 |
| Pages: |
1175-86 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Hepsin is a serine protease that cleaves extracellular substrates, and contributes to the proteolytic processing of growth factors, such as HGF and MST1/HGFL [, ]. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kadoyama K |
| Year: |
2009 |
| Journal: |
Neurosci Res |
| Title: |
Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS. |
| Volume: |
65 |
| Issue: |
2 |
| Pages: |
194-200 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 1, Toshikazu Nakamura |
| Allele Type: |
Transgenic |
| Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion 24, Tiziana Crepaldi |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence, Reporter |
|
•
•
•
•
•
|
| Allele |
| Name: |
transgene insertion, Adolf Garcia-Ocana |
| Allele Type: |
Transgenic |
| Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Leo C |
| Year: |
2011 |
| Journal: |
PLoS One |
| Title: |
Activated Met signalling in the developing mouse heart leads to cardiac disease. |
| Volume: |
6 |
| Issue: |
2 |
| Pages: |
e14675 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Morena D |
| Year: |
2016 |
| Journal: |
Elife |
| Title: |
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes. |
| Volume: |
5 |
|
|
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
This entry includes hepatocyte growth factor (HGF; also called scatter factor) and HGF-like proteins (also known as macrophage stimulatory protein, MST1). Hepatocyte growth factor (HGF) is an activating ligand of the Met receptor tyrosine kinase, whose activity is essential for normal tissue development and organ regeneration []. HGF is essential for placental, liver, and muscle development, whereas MST1 is not required for embryogenesis, fertility, or wound healing. Genes for HGF and its receptor, the Met tyrosine kinase, are close together on chromosome 7, so that polysomy of chromosome 7 may contribute to malignancy through overproduction of both molecules. MST1 and its receptor, the Ron tyrosine kinase, are close together on chromosome 3. HGF and MST1 are closely related to plasminogen, having similar domain architecture: signal sequence followed by a PAN (formerly apple) domain, four (rather than five) kringle domains, and a trypsin domain, which appears to lack any peptidase activity. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Hepatocyte growth factor (HGF) is an activating ligand of the tyrosine kinase receptor Met. It activates Met by binding and promoting its dimerisation. This activation has been linked to promoting the invasive growth of many tumour types []. HGF acts as growth factor for a broad spectrum of tissues and cell types and has no detectable protease activity [].Defects in HGF are the cause of deafness autosomal recessive type 39 (DFNB39). A form of profound prelingual sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kadoyama K |
| Year: |
2007 |
| Journal: |
Neurosci Res |
| Title: |
Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. |
| Volume: |
59 |
| Issue: |
4 |
| Pages: |
446-56 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, endonuclease-mediated mutation, spontaneous mutation, mutant strain |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
coisogenic, mutant strain, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Holland JD |
| Year: |
2013 |
| Journal: |
Cell Rep |
| Title: |
Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome. |
| Volume: |
5 |
| Issue: |
5 |
| Pages: |
1214-27 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cd44/Cd44 Hgf/Hgf<+> |
| Background: |
involves: 129S4/SvJae * C57BL/6 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
targeted mutation, transgenic, mutant strain |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Valenti G |
| Year: |
2017 |
| Journal: |
Cancer Res |
| Title: |
Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors. |
| Volume: |
77 |
| Issue: |
8 |
| Pages: |
2134-2147 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, mutant stock |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ctnnb1/Ctnnb1<+> Tg(Wap-cre)11738Mam/? Tg(Wap-Hgf)402Mig/? |
| Background: |
FVB.Cg-Ctnnb1 Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Ggt1-tTA)#Agoc/? Tg(tetO/CMV-Hgf)#Agoc/? |
| Background: |
involves: CD-1 |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(CKMM-tTA)A3Rhvh/? Tg(tetO-Hgf,-EGFP)24Tcre/? |
| Background: |
involves: FVB |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McIntyre BA |
| Year: |
2004 |
| Journal: |
Gene Expr Patterns |
| Title: |
Glomulin is predominantly expressed in vascular smooth muscle cells in the embryonic and adult mouse. |
| Volume: |
4 |
| Issue: |
3 |
| Pages: |
351-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McMullen BA |
| Year: |
1991 |
| Journal: |
Biochemistry |
| Title: |
Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. |
| Volume: |
30 |
| Issue: |
8 |
| Pages: |
2056-60 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Brown PJ |
| Year: |
2001 |
| Journal: |
FEBS Lett |
| Title: |
Domains of invasion organelle proteins from apicomplexan parasites are homologous with the Apple domains of blood coagulation factor XI and plasma pre-kallikrein and are members of the PAN module superfamily. |
| Volume: |
497 |
| Issue: |
1 |
| Pages: |
31-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhou H |
| Year: |
1998 |
| Journal: |
Structure |
| Title: |
The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. |
| Volume: |
6 |
| Issue: |
1 |
| Pages: |
109-16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
MacMillan D |
| Year: |
2005 |
| Journal: |
J Cell Sci |
| Title: |
In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin. |
| Volume: |
118 |
| Issue: |
Pt 23 |
| Pages: |
5443-51 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
Plasma kallikrein () and coagulation factor XI () are two related plasma serine proteases activated by factor XIIA and which share the same domain topology: an N-terminal region that contains four tandem repeats of about 90 amino acids and a C-terminal catalytic domain. The 90 amino-acid repeated domain contains 6 conserved cysteines. It has been shown [, ]that three disulfide bonds link the first and sixth, second and fifth, and third and fourth cysteines. The domain can be drawn in the shape of an apple and has been accordingly called the 'apple domain'.The apple domains of plasma prekallikrein are known to mediate its binding to high molecular weight kininogen [], the apple domains of factor XI bind to factor XIIa, platelets, kininogen, factor IX and heparin [].The apple domains display some sequence similarity with the N domain of plasminogen/hepatocyte growth factor (HGF) and to some nematode and protozoan proteins []. They all belong to the same domain superfamily that have been called the PAN module []. The N domain of hepatocyte growth factor binds to the c-Met receptor and to the heparin molecule. The structure of the PAN module of HGF has been solved. It contains a characteristic hairpin-loop structure stabilised by two disulfide bridges, Cys-1 and 6 are not conserved in HGF PAN modules [].Apart from the cysteines, there are a number of other conserved positions in the apple domain. This entry represents the PAN domain of the plasma kalllikrein/coagulation factor XI subgroup proteins. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
In the human adult, FKBP-12, also known as FAP68 or FK506-binding protein, (protein product of the gene glomulin) is expressed at highlevels in skeletal muscle, heart, brain and kidney, and at low levels in smaller arteries and veins. The high expression of glomulin in murine vasculature suggests an important role in blood vessel development and/or maintenance, which is supported by the vascular phenotype seen in GVM patients with mutations in this gene []. It is a cytoplasmic protein, specifically bound by the non-phosphorylated form of the hepatocyte growth factor, HGF, receptor and is released upon HGF stimulation and receptor phosphorylation, suggesting a potential role for FKBP12 in linking HGF signaling to the regulation of protein synthesis []. FKBP12 is found to regulate Ca2+release from the sarcoplasmic reticulum (SR) by its action on the IP3 receptors (IP3Rs), which crucially regulate diverse cell signalling processes from reproduction to apoptosis, possibly via the kinase rapamycin (mTOR), that potentiates Ca2+ release from the IP3R in smooth muscle []. This entry also include the aberrant root formation protein 4 (At5g11030) from Arabidopsis. It is required for the initiation of lateral roots independent from auxin signaling []. |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant strain, congenic, targeted mutation, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Quinn HM |
| Year: |
2021 |
| Journal: |
Cancer Res |
| Title: |
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer. |
| Volume: |
81 |
| Issue: |
8 |
| Pages: |
2116-2127 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Tg(Eno2-Hgf)1Tnak/? Tg(SOD1*G93A)1Gur/? |
| Background: |
involves: C57BL/6 * C57BL/6J * SJL/J |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ctnnb1/Ctnnb1<+> Cxcr4/Cxcr4 Tg(Wap-cre)11738Mam/? Tg(Wap-Hgf)402Mig/? |
| Background: |
FVB.Cg-Cxcr4 Ctnnb1 Tg(Wap-cre)11738Mam Tg(Wap-Hgf)402Mig |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Tg(CKMM-tTA)A3Rhvh/? Tg(tetO-Hgf,-EGFP)24Tcre/? |
| Background: |
involves: 129X1/SvJ * FVB |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a<+> Tg(CKMM-tTA)A3Rhvh/? Tg(tetO-Hgf,-EGFP)24Tcre/? |
| Background: |
involves: 129X1/SvJ * FVB |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Pax7/Pax7 Tg(CKMM-tTA)A3Rhvh/? Tg(tetO-Hgf,-EGFP)24Tcre/? |
| Background: |
involves: 129S2/SvPas * 129X1/SvJ * FVB |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Pax7/Pax7<+> Tg(CKMM-tTA)A3Rhvh/? Tg(tetO-Hgf,-EGFP)24Tcre/? |
| Background: |
involves: 129S2/SvPas * 129X1/SvJ * FVB |
| Zygosity: |
cx |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
596
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
596
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
532
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
97
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
100
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tordai H |
| Year: |
1999 |
| Journal: |
FEBS Lett |
| Title: |
The PAN module: the N-terminal domains of plasminogen and hepatocyte growth factor are homologous with the apple domains of the prekallikrein family and with a novel domain found in numerous nematode proteins. |
| Volume: |
461 |
| Issue: |
1-2 |
| Pages: |
63-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Grisendi S |
| Year: |
2001 |
| Journal: |
J Biol Chem |
| Title: |
Ligand-regulated binding of FAP68 to the hepatocyte growth factor receptor. |
| Volume: |
276 |
| Issue: |
49 |
| Pages: |
46632-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
DiDonato RJ |
| Year: |
2004 |
| Journal: |
Plant J |
| Title: |
Arabidopsis ALF4 encodes a nuclear-localized protein required for lateral root formation. |
| Volume: |
37 |
| Issue: |
3 |
| Pages: |
340-53 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bottaro DP |
| Year: |
1991 |
| Journal: |
Science |
| Title: |
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. |
| Volume: |
251 |
| Issue: |
4995 |
| Pages: |
802-4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang MH |
| Year: |
1994 |
| Journal: |
Science |
| Title: |
Identification of the ron gene product as the receptor for the human macrophage stimulating protein. |
| Volume: |
266 |
| Issue: |
5182 |
| Pages: |
117-9 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []:Serine/threonine-protein kinasesTyrosine-protein kinasesDual specificity protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins)Protein kinase function is evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases [].Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []:Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases [].This entry represents the receptor tyrosine kinases for HGF (hepatocyte growth factor) and MSP (macrophage-stimulating protein) []. The HGF receptor functions in cell proliferation, scattering, morphogenesis and survival [, ]. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McMullen BA |
| Year: |
1991 |
| Journal: |
Biochemistry |
| Title: |
Location of the disulfide bonds in human plasma prekallikrein: the presence of four novel apple domains in the amino-terminal portion of the molecule. |
| Volume: |
30 |
| Issue: |
8 |
| Pages: |
2050-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Herwald H |
| Year: |
1996 |
| Journal: |
J Biol Chem |
| Title: |
Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4. |
| Volume: |
271 |
| Issue: |
22 |
| Pages: |
13061-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ho DH |
| Year: |
1998 |
| Journal: |
J Biol Chem |
| Title: |
A binding site for heparin in the apple 3 domain of factor XI. |
| Volume: |
273 |
| Issue: |
26 |
| Pages: |
16382-90 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
137
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Helmbacher F |
| Year: |
2003 |
| Journal: |
Neuron |
| Title: |
Met signaling is required for recruitment of motor neurons to PEA3-positive motor pools. |
| Volume: |
39 |
| Issue: |
5 |
| Pages: |
767-77 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kurita K |
| Year: |
2005 |
| Journal: |
J Invest Dermatol |
| Title: |
Suppression of progressive loss of coat color in microphthalmia-vitiligo mutant mice. |
| Volume: |
125 |
| Issue: |
3 |
| Pages: |
538-44 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Toh B |
| Year: |
2011 |
| Journal: |
PLoS Biol |
| Title: |
Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. |
| Volume: |
9 |
| Issue: |
9 |
| Pages: |
e1001162 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Glodde N |
| Year: |
2017 |
| Journal: |
Immunity |
| Title: |
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy. |
| Volume: |
47 |
| Issue: |
4 |
| Pages: |
789-802.e9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shanmukhappa K |
| Year: |
2009 |
| Journal: |
J Biol Chem |
| Title: |
Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair. |
| Volume: |
284 |
| Issue: |
19 |
| Pages: |
12917-23 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Komarowska I |
| Year: |
2015 |
| Journal: |
Immunity |
| Title: |
Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release. |
| Volume: |
42 |
| Issue: |
6 |
| Pages: |
1087-99 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chu SY |
| Year: |
2019 |
| Journal: |
Nat Commun |
| Title: |
Mechanical stretch induces hair regeneration through the alternative activation of macrophages. |
| Volume: |
10 |
| Issue: |
1 |
| Pages: |
1524 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Santoni-Rugiu E |
| Year: |
1996 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. |
| Volume: |
93 |
| Issue: |
18 |
| Pages: |
9577-82 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Segarra J |
| Year: |
2006 |
| Journal: |
J Biol Chem |
| Title: |
Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for met-triggered cortical neuron migration. |
| Volume: |
281 |
| Issue: |
8 |
| Pages: |
4771-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lin Y |
| Year: |
2017 |
| Journal: |
Nat Commun |
| Title: |
HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells. |
| Volume: |
8 |
| Issue: |
1 |
| Pages: |
1175 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shiota G |
| Year: |
1992 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. |
| Volume: |
89 |
| Issue: |
1 |
| Pages: |
373-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mizuno M |
| Year: |
2021 |
| Journal: |
Cancers (Basel) |
| Title: |
Adipsin-Dependent Secretion of Hepatocyte Growth Factor Regulates the Adipocyte-Cancer Stem Cell Interaction. |
| Volume: |
13 |
| Issue: |
16 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ishibe S |
| Year: |
2003 |
| Journal: |
Mol Cell |
| Title: |
Phosphorylation-dependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. |
| Volume: |
12 |
| Issue: |
5 |
| Pages: |
1275-85 |
|
•
•
•
•
•
|